MARWA AHADY: Open Payments
NPI 1881280113 · EL MONTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$924 in 32 payments from 16 companies in 2025. Trend: 2023 $66 · 2024 $1,197 · 2025 $924
Food & beverage: $914Education: $10
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 5 | $208 |
| ABBVIE INC. | 5 | $175 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $84 |
| Arcutis Biotherapeutics, Inc. | 3 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $60 |
| Incyte Corporation | 2 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| Botanix SB Inc | 1 | $26 |
Products named: Bimzelx, BOTOX, ILUMYA, Zoryve, OPZELURA, DUPIXENT, TALTZ, Sotyktu.
Industry payments across CA — which companies pay providers there.
